Related Experiment Videos
Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalities of
Abstract:
For the purpose of examining the mechanisms for the overproduction of megakaryocytes and platelets in essential thrombocythemia (ET), marrow megakaryocytic colony-forming units (CFU-Meg) were characterized using a methylcellulose culture system in nine patients with ET, and they were compared with those of 16 control subjects and four patients with secondary thrombocytosis (ST). The number of CFU-Meg per 10(5) cells in ET was significantly higher (p less than .001) than that in the controls (5.8 times of the controls) or that in ST. ET showed endogenous CFU-Meg (58 +/- 16% of the total CFU-Meg) that could form megakaryocytic colonies without phytohemagglutinin-stimulated leukocyte-conditioned medium (PHA-LCM) as a source of Meg-CSA. The controls and the patients with St revealed no endogenous CFU-Meg. The dose-response studies with PHA-LCM revealed that CFU-Meg from ET are highly sensitive to low concentrations of PHA-LCM compared to CFU-Meg from the control and ST. Erythropoietic burst-forming units (BFU-E) were monitored as a control progenitor, because the patients with ET studied did not have erythrocytosis. Although five out of nine patients with ET had endogenous BFU-E, the percentages of endogenous BFU-E were small (4-10%). The number of BFU-E in ET was not different from the control value. Thus, ET is associated with an enlarged CFU-Meg compartment that shows abnormal growth patterns when cultured in vitro, while the growth abnormality of BFU-E is small, which may underlie the hematological features of ET. The culture of CFU-Meg should be clinically useful for differentiating ET from ST.
Insights
Essential thrombocythemia (ET) shows significantly increased megakaryocyte progenitors (CFU-Meg) with abnormal growth patterns, distinguishing it from secondary thrombocytosis. This finding may help differentiate ET from other conditions.
Area of Science:
- Hematology
- Cell Biology
- Oncology
Background:
- Essential thrombocythemia (ET) is characterized by the overproduction of megakaryocytes and platelets.
- Understanding the underlying mechanisms of this overproduction is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate the mechanisms behind megakaryocyte and platelet overproduction in ET.
- To characterize megakaryocytic colony-forming units (CFU-Meg) in ET patients and compare them to controls and patients with secondary thrombocytosis (ST).
Main Methods:
- Methylcellulose culture system was used to characterize CFU-Meg from nine ET patients, 16 controls, and four ST patients.
- Endogenous CFU-Meg and sensitivity to phytohemagglutinin-stimulated leukocyte-conditioned medium (PHA-LCM) were assessed.
- Erythropoietic burst-forming units (BFU-E) were monitored as a control progenitor.
Main Results:
- ET patients exhibited significantly higher numbers of CFU-Meg compared to controls and ST patients (5.8 times higher).
- ET patients showed a substantial percentage of endogenous CFU-Meg (58%), absent in controls and ST patients.
- ET CFU-Meg demonstrated hypersensitivity to low PHA-LCM concentrations, unlike controls and ST.
- BFU-E levels were comparable between ET patients and controls, with minimal endogenous BFU-E in ET.
Conclusions:
- ET is associated with an expanded CFU-Meg compartment exhibiting abnormal in vitro growth patterns.
- The distinct CFU-Meg characteristics in ET suggest their utility in differentiating ET from ST.
- Abnormalities in CFU-Meg, rather than BFU-E, likely underlie the hematological features of ET.